Table 5 Mean differences between and within groups of included studies
Trial | Difference between groups | Differences within groups | ||
|---|---|---|---|---|
Tillu and Gupta (1998) | N/A (one group only) | (i) VAS pain: Â Â Â @ 4 weeks (34.7% improvement, p < 0.001) Â Â Â @ 6 weeks (67.9% improvement, p < 0.001) Â Â Â @ 6 weeks vs 4 weeks, (difference 33.2%, p = 0.047) | ||
| Â | Â | (ii) Verbal pain score (% of improvement): 40.2 (40.1%) @ 4 weeks and 65.9 (32.8%) @ 6 weeks | Â | Â |
| Â | Â | Â | Intervention | Control |
Imamura et al. (1998) | Duration of treatment (weeks): Significantly less in intervention group (83.9% difference between the groups, p < 0.05) | (i) Mean duration of treatment in weeks (SD) (ii) VAS pain:    @ discharge    @ 6 months    @ 2 years | 3.4 (2.2) 58.4% improvement, p = 0.003 67.1% improvement, p = 0.007 67.1% improvement p = 0.002 | 21.1 (19.5) 54.9% improvement, p < 0.05 values not reported at 6 months values not reported at 12 months |
|  |  | (iii) PPT (gastrocnemius):    @ discharge    @ 6 months    @ 2 years | 130% increase, p = 0.001 71% increase, p = 0.009 55% increase, p = 0.023 | PPT not reported for control |
|  |  | (iv) PPT (medial calcaneal tubercle) at:    @ discharge    @ 6 months    @ 2 years | 106% increase, p = 0.004 values not reported at 6    months 143% increase, p = 0.007 | PPT not reported for control |
Perez-Millan and Foster (2001) | N/A (one group only) | (i) VAS pain: Â Â Â @ 6 weeks (46% improvement, p < 0.001) | ||
| Â | Â | (ii) Foot function index questionnaire scores*: Â Â Â significantly less pain for 10 out of 12 | Â | Â |